Complete genomic screen in Parkinson disease: evidence for multiple genes

JAMA. 2001 Nov 14;286(18):2239-44. doi: 10.1001/jama.286.18.2239.

Abstract

Context: The relative contribution of genes vs environment in idiopathic Parkinson disease (PD) is controversial. Although genetic studies have identified 2 genes in which mutations cause rare single-gene variants of PD and observational studies have suggested a genetic component, twin studies have suggested that little genetic contribution exists in the common forms of PD.

Objective: To identify genetic risk factors for idiopathic PD.

Design, setting, and participants: Genetic linkage study conducted 1995-2000 in which a complete genomic screen (n = 344 markers) was performed in 174 families with multiple individuals diagnosed as having idiopathic PD, identified through probands in 13 clinic populations in the continental United States and Australia. A total of 870 family members were studied: 378 diagnosed as having PD, 379 unaffected by PD, and 113 with unclear status.

Main outcome measures: Logarithm of odds (lod) scores generated from parametric and nonparametric genetic linkage analysis.

Results: Two-point parametric maximum parametric lod score (MLOD) and multipoint nonparametric lod score (LOD) linkage analysis detected significant evidence for linkage to 5 distinct chromosomal regions: chromosome 6 in the parkin gene (MLOD = 5.07; LOD = 5.47) in families with at least 1 individual with PD onset at younger than 40 years, chromosomes 17q (MLOD = 2.28; LOD = 2.62), 8p (MLOD = 2.01; LOD = 2.22), and 5q (MLOD = 2.39; LOD = 1.50) overall and in families with late-onset PD, and chromosome 9q (MLOD = 1.52; LOD = 2.59) in families with both levodopa-responsive and levodopa-nonresponsive patients.

Conclusions: Our data suggest that the parkin gene is important in early-onset PD and that multiple genetic factors may be important in the development of idiopathic late-onset PD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Antiparkinson Agents / therapeutic use
  • Chromosomes, Human, Pair 17
  • Chromosomes, Human, Pair 3
  • Chromosomes, Human, Pair 5
  • Chromosomes, Human, Pair 6
  • Chromosomes, Human, Pair 8
  • Chromosomes, Human, Pair 9
  • Drug Resistance
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Levodopa / therapeutic use
  • Ligases / genetics
  • Lod Score
  • Microsatellite Repeats
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / epidemiology
  • Parkinson Disease / genetics*
  • Risk Factors
  • Ubiquitin-Protein Ligases*

Substances

  • Antiparkinson Agents
  • Levodopa
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Ligases